Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 80425-0472

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 80425-0472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine HCl Er 75mg #30 (Venlafaxine HCl Er 75mg 80425 0472 01)

Packaging label for Venlafaxine Hydrochloride 75 mg extended release capsules by Advanced Rx of Tennessee, LLC. The label includes storage instructions, comparison to Effexor XR, NDC codes, lot number, expiration date, barcodes, and a note that the product is Rx only. Also includes manufacturer information for Granules Pharma.*

FDA Label Image

Venlafaxine HCl Er 75mg #60 (Venlafaxine HCl Er 75mg 80425 0472 02)

Label for Venlafaxine Hydrochloride Extended Release 75 mg capsule by Advanced Rx of Tennessee, LLC. The label references comparison to Effexor XR and displays NDC codes 80425-0472-02 and 70010-0185-09. It lists lot number and expiration date 1/1/2027 and includes barcode and storage instructions.*

FDA Label Image

Venlafaxine HCl Er 75mg #90 (Venlafaxine HCl Er 75mg 80425 0472 03)

Venlafaxine Hydrochloride 75 mg extended release oral capsules label from Advanced Rx of Tennessee, LLC. The label includes NDC information, lot number, expiration date of 1/1/2027, and a warning about federal restrictions on drug transfer. Packaging contains 90 capsules.*

FDA Label Image

Figure-1 (Figure 1)

A scatter plot chart showing the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax, AUC, and ODV) of venlafaxine in various special populations including hepatic and renal impairment, CYP2D6 polymorphisms, age, and gender. The x-axis represents change relative to the reference value, highlighting variability in drug exposure among groups.*

FDA Label Image

Figure-2 (Figure 2)

A dot plot chart illustrating the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC) of venlafaxine and O-desmethylvenlafaxine (ODV) when co-administered with various interacting drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis represents the change relative to a reference value, ranging from 0 to 3.*

FDA Label Image

Figure-3 (Figure 3)

A dot plot chart depicting fold changes and 90% confidence intervals for various interacting drugs and their analytes, measured by pharmacokinetic parameters Cmax and AUC. The x-axis represents the change relative to a reference value, with several drugs plotted showing increases or decreases in fold change compared to the reference.*

FDA Label Image

Structure (Structure)

Chemical structure of venlafaxine hydrochloride showing the molecular arrangement of atoms including a cyclohexane ring, aromatic ring with methoxy group, and dimethylamino group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.